[1]
Lechowska, Z. et al. 2026. NATALIZUMAB IN MULTIPLE SCLEROSIS – A REVIEW OF DIFFERENT DOSING REGIMENS, SIDE EFFECTS, COMPARISON WITH OTHER DISEASE-MODIFYING THERAPIES WITH ADDITIONAL ATTENTION TO USE IN PREGNANCY AND THE PEDIATRIC POPULATION. International Journal of Innovative Technologies in Social Science. 2, 3(51) (Aug. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.5801.